Speakers

Michael Cottler joined Gemini Law as a partner in 2023. Michael has over 17 years of experience handling and managing IP litigation and strategy in the pharmaceutical and biotech sector. Michael brings a unique commercial perspective to Gemini. Previously, Michael was Global Head of Litigation at Alvotech, a multinational biopharmaceutical company focused on the development and manufacture of biosimilars for global markets. There he directed the company’s global prelitigation, litigation, and dispute resolution strategy, including BPCIA litigation, as well as advising on legal risk and strategy associated with global supply chain and market entry. He also gained deep knowledge concerning the development, manufacture, regulatory approval, and commercialization of biologics. Prior to Alvotech, Michael was a partner at Goodwin Procter, where he focused on the life sciences sector and oversaw all aspects of patent litigation, from prelitigation strategy through trial and appeal, as well as contract dispute resolution. He has published and spoken extensively regarding biotech/pharma patent litigation. While at Goodwin, he was also a Senior Editor of the firm’s treatise, Guide to Guide to Biosimilars Litigation and Regulation in the U.S. (published by Thomson-Reuters). Michael holds a bachelor’s degree in Biologics Sciences (with a neuroscience focus) from Cornell University.